Sclerostin-erbB-3 interactions: modulation of erbB-3 activity by sclerostin.

[1]  D. Mukhopadhyay,et al.  Sclerostin binds and regulates the activity of cysteine-rich protein 61. , 2010, Biochemical and biophysical research communications.

[2]  H. Vrieling,et al.  Wnt but Not BMP Signaling Is Involved in the Inhibitory Action of Sclerostin on BMP‐Stimulated Bone Formation , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  Scott Saunders,et al.  Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[4]  C. Löwik,et al.  Wnt signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation. , 2006, Journal of musculoskeletal & neuronal interactions.

[5]  J. Latham,et al.  Sclerostin Inhibition of Wnt-3a-induced C3H10T1/2 Cell Differentiation Is Indirect and Mediated by Bone Morphogenetic Proteins* , 2005, Journal of Biological Chemistry.

[6]  J. Latham,et al.  Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex* , 2004, Journal of Biological Chemistry.

[7]  M. Karperien,et al.  Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist , 2004, The Journal of experimental medicine.

[8]  John A Latham,et al.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist , 2003, The EMBO journal.

[9]  Nobuyuki Itoh,et al.  Sclerostin Is a Novel Secreted Osteoclast-derived Bone Morphogenetic Protein Antagonist with Unique Ligand Specificity* , 2003, Journal of Biological Chemistry.

[10]  R. Wong.  Transgenic and knock-out mice for deciphering the roles of EGFR ligands , 2003, Cellular and Molecular Life Sciences CMLS.

[11]  L. Hofbauer,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[12]  D. Galas,et al.  A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population. , 2002, American journal of medical genetics.

[13]  Richard P Lifton,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[14]  Mark L. Johnson,et al.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. , 2002, American journal of human genetics.

[15]  Mark L. Johnson,et al.  High bone density due to a mutation in LDL-receptor-related protein 5. , 2002, The New England journal of medicine.

[16]  K. Ishizeki,et al.  Formation of the sphenomandibular ligament by Meckel's cartilage in the mouse: possible involvement of epidermal growth factor as revealed by studies in vivo and in vitro , 2001, Cell and Tissue Research.

[17]  D. Galas,et al.  Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. , 2001, American journal of human genetics.

[18]  R. Wong,et al.  Expression of Epidermal Growth Factor in Transgenic Mice Causes Growth Retardation* , 2000, The Journal of Biological Chemistry.

[19]  T. Huh,et al.  Epidermal Growth Factor Negatively Regulates Chondrogenesis of Mesenchymal Cells by Modulating the Protein Kinase C-α, Erk-1, and p38 MAPK Signaling Pathways* , 2000, The Journal of Biological Chemistry.

[20]  T. Huh,et al.  Epidermal growth factor negatively regulates chondrogenesis of mesenchymal cells by modulating the protein kinase C-alpha, Erk-1, and p38 MAPK signaling pathways. , 2000, The Journal of biological chemistry.

[21]  Katsu Takahashi,et al.  Convergence of the BMP and EGF signaling pathways on Smad1 in the regulation of chondrogenesis. , 1999, The International journal of developmental biology.

[22]  R. Derynck,et al.  Epidermal growth factor receptor function is necessary for normal craniofacial development and palate closure , 1999, Nature Genetics.

[23]  V. Scranton,et al.  Roles of Transforming Growth Factor-α and Epidermal Growth Factor in Chick Limb Development , 1998 .

[24]  H. Cheng,et al.  Roles of transforming growth factor-alpha and epidermal growth factor in chick limb development. , 1998, Developmental biology.

[25]  B. Hall,et al.  Chondrogenesis of mandibular mesenchyme from the embryonic chick is inhibited by mandibular epithelium and by epidermal growth factor. , 1989, The International journal of developmental biology.

[26]  E. Canalis,et al.  Isolation of EGF‐dependent transforming growth factor (TGFβ‐like) activity from culture medium conditioned by fetal rat calvariae , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  P. Beighton,et al.  A review of the osteopetroses. , 1977, Postgraduate medical journal.

[28]  P. Beighton,et al.  Sclerosteosis — An autosomal recessive disorder , 1977, Clinical genetics.

[29]  P. Beighton,et al.  The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals. , 1976, Annals of internal medicine.